At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.
Job Summary:
* Prioritizes activities across multiple projects in the assigned TA and effectively negotiates plans with colleagues and customers.
* Communicates the role of pharmacoepidemiology within GPV&E and throughout BMS.
* Applies theoretical principles to real problems and bridge uncertainty of the real world with innovative pharmacoepidemiologic solutions.
* Evaluates risk-benefit of pharmaceuticals in context of worldwide regulatory agency use of epidemiologic data.
* Advises on pharmacoepidemiology principles to others in R&D.
* Ensures that all tasks are performed in the most efficient manner possible commensurate with quality, accuracy, and timeliness; and in accordance with current global regulatory requirements, good pharmacoepidemiology guidelines, and BMS cost effectiveness goals.
* Support database build and other data management programming activities.
* Writing production code for scraping websites and PDFs to feed into NLP models.
* Develop and implement NLP-based information extraction solutions.
* Create risk prediction models for adverse events using varying methodologic techniques.
Qualifications:
* PhD in epidemiology or (MD, DO), MPH
* At least 3-5 years experience in the pharmaceutical industry, some management experience preferred or MS or PhD in Computer Science, Math, Life sciences or equivalent fields with 5+ years of programming experience and 3+ years of pharmaceutical industry experience.
* Up-to-date knowledge of machine learning , natural language processing (NLP), and data analytics tools and techniques.
* Demonstrated experience with data mining including web scraping, APIs, big data workflows/tools, and/or text mining.
* Programming experience with SQL for querying relational databases, data cleaning, and analysis.
* Prior experience with clinical data.
* Knowledge about SDTM data standards is preferred.
* Strong knowledge of Python, and related machine learning tools (e.g. TensorFlow, PyTorch).
* Hands on experience with DASH/HTML is preferred.
Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.
Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.
New York, New York
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The company’s products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with moderately to severely active RA and prostate-specific antigen, as well as reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis.
It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, the company offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV) and Evotaz; Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. It has collaboration agreements with Nektar Therapeutics; Janssen Pharmaceuticals, Inc.; Biocartis Group NV.; and FameWave Ltd.
The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.